Beobachten
- Press release BoxID 517908
Sartorius Stedim Biotech and Bosch Packaging Technology Announce Global Collaboration
(PresseBox) (Goettingen / Crailsheim, Germany, )
Sartorius Stedim Biotech (SSB), a leading international pharma and biotech supplier, and Bosch Packaging Technology (Bosch), one of the leading providers of process technology and packaging solutions for the pharmaceutical industry, today announced a long-term global partnership agreement. The agreement covers the mutual design and development of single-use filling solutions to be used on Bosch's aseptic filling equipment for final fill-and-finish operations of drug products. SSB will provide Bosch with pre-configured single-use filling transfer sets, consisting of bags, filters, tubing and connectors. Bosch will combine them with its aseptic filling and barrier isolation technology into new, innovative systems for aseptic filling, and exclusively market, distribute and service these new filling systems under its own brand name.
With the new product line PreVAS (Pre-Validated, Pre-Assembled, Pre-Sterilized), Bosch will supply its customers with highly cost effective, plug and play tools for aseptic filling operations that provide additional flexibility and come along with comprehensive validation packages. PreVAS will be launched at Achema 2012.
Joachim Brenner, responsible for Bosch's Pharma Liquid portfolio worldwide and Site Manager of the plant Crailsheim, stated: "By integrating SSB's single-use technologies into our aseptic filling systems, we are expanding our product and service portfolio in the area of fill-and-finish unit operations by an important component. With our joint expertise, we intend to develop configurable and customized single-use filling solutions and to provide strong validation and technical support."
Jean-Marc Cappia, Vice President of Marketing, Fluid Management Technologies, at SSB stated: "The partnership with Bosch promotes the implementation of single-use technologies into critical applications such as final filling operations and strengthens the confidence into single-use technology. Our customers from the pharmaceutical and biopharmaceutical industry are facing mounting cost pressure and time constraints. By integrating single-use technology into fill-and-finish unit operations, they can handle smaller batches and product change overs in a safe, economic and flexible way."
Bosch Packaging Technology
The Bosch division Packaging Technology, based in Waiblingen (Germany ), is one of the leading suppliers in the field of processing and packaging technology. In more than 15 countries worldwide it develops and produces complete solutions for the pharmaceutical, food and confectionery industries. The comprehensive service portfolio completes the package. The worldwide sales and service network offers local contacts.
Bosch Packaging Technology - Pharma is one of the leading providers of process technology and packaging solutions for the pharmaceutical industry. The portfolio includes single units, systems and complete solutions for process technology of sterile liquids and powder processing. It also comprises primary packaging for sterile fill&finish and solid dosage forms, secondary packaging as well as inspection technology, qualification, validation and services. The following product brands are part of Bosch's pharma portfolio: Hüttlin, Manesty, Moeller&Devicon, Pharmatec, SBM Schoeller-Bleckmann Medizintechnik, Sigpack and Valicare.
With the new product line PreVAS (Pre-Validated, Pre-Assembled, Pre-Sterilized), Bosch will supply its customers with highly cost effective, plug and play tools for aseptic filling operations that provide additional flexibility and come along with comprehensive validation packages. PreVAS will be launched at Achema 2012.
Joachim Brenner, responsible for Bosch's Pharma Liquid portfolio worldwide and Site Manager of the plant Crailsheim, stated: "By integrating SSB's single-use technologies into our aseptic filling systems, we are expanding our product and service portfolio in the area of fill-and-finish unit operations by an important component. With our joint expertise, we intend to develop configurable and customized single-use filling solutions and to provide strong validation and technical support."
Jean-Marc Cappia, Vice President of Marketing, Fluid Management Technologies, at SSB stated: "The partnership with Bosch promotes the implementation of single-use technologies into critical applications such as final filling operations and strengthens the confidence into single-use technology. Our customers from the pharmaceutical and biopharmaceutical industry are facing mounting cost pressure and time constraints. By integrating single-use technology into fill-and-finish unit operations, they can handle smaller batches and product change overs in a safe, economic and flexible way."
Bosch Packaging Technology
The Bosch division Packaging Technology, based in Waiblingen (Germany ), is one of the leading suppliers in the field of processing and packaging technology. In more than 15 countries worldwide it develops and produces complete solutions for the pharmaceutical, food and confectionery industries. The comprehensive service portfolio completes the package. The worldwide sales and service network offers local contacts.
Bosch Packaging Technology - Pharma is one of the leading providers of process technology and packaging solutions for the pharmaceutical industry. The portfolio includes single units, systems and complete solutions for process technology of sterile liquids and powder processing. It also comprises primary packaging for sterile fill&finish and solid dosage forms, secondary packaging as well as inspection technology, qualification, validation and services. The following product brands are part of Bosch's pharma portfolio: Hüttlin, Manesty, Moeller&Devicon, Pharmatec, SBM Schoeller-Bleckmann Medizintechnik, Sigpack and Valicare.
About Sartorius AG
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of "turning science into solutions." Headquartered in Aubagne, France , Sartorius Stedim Biotech is listed on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany. The company employs approx. 2,850 people, and in 2011 earned sales revenue of 477.3 million euros.
You might also be interested in
|
Fachtagung 2013 des Gissel Instituts: Aktuelle Themen rund um die Fleischverarbeitung stehen im Blickpunkt
, Biotechnology, Gissel Institut für Bakteriologie und Hygiene
Kaum eine Veranstaltung dürfte geeigneter sein, sich in Sachen Fleisch und Fleischwaren auf den neuesten Stand zu bringen, als die regelmäßige Fachtagung des renommierten...
|
Reading und Imaging vereint im neuen, revolutionären Cytation™3 von BioTek
, Biotechnology, BIOTEK Instruments GmbH
BioTek kündigt stolz die erste Kombination aus Multi-Detektions-Reader mit Hybrid-Technologie und Imaging-System an - den Cytation™3 Multi-Detektions-Reader für...
|
New Roche Award for Antibody-based Cancer Therapy Research
, Biotechnology, Roche Diagnostics GmbH
In a newly created award, pRED's Discovery Oncology unit of Roche (SIX: RO, ROG; OTCQX: RHHBY) in Penzberg, Germany invites European researchers to submit abstracts...
